Global Single-Chamber Prefilled Syringes Markets Report 2015-2020 & 2021-2030 Featuring Major Players - BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, Terumo -

·3 min read

DUBLIN, January 21, 2022--(BUSINESS WIRE)--The "Global Single-Chamber Prefilled Syringes Market Report 2021: COVID-19 Growth and Change" report has been added to's offering.

The global single-chamber prefilled syringes market is expected to grow from $4.41 billion in 2020 to $4.97 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%. The market is expected to reach $7.58 billion in 2025 at a CAGR of 11.1%.

Major players in the single-chamber prefilled syringes market are BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, and Terumo.

The single-chamber prefilled syringes market consists of sales of single-chamber prefilled syringes by entities (organizations, sole traders, and partnerships) that manufacture disposable single-chamber syringes with already loaded liquid medicine to be injected. The companies involved in the single-chamber prefilled syringes market are primarily engaged in the development, manufacturing, and marketing of single-chamber prefilled syringes.

The growing technological advancements are shaping the single-chamber prefilled syringe market. Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position.

For instance, in 2019, Biocorp, a France-based medical device manufacturing company launched Injay, a single-chamber prefilled syringe that uses Near Field Communication (NFC) chip to stores information regarding drug name, batch number, and expiry date and transfers this data when it is scanned using the code provided. This information will be transmitted from the patient's phone to the doctor with the specified date and time when the patient injected the drug.

In October 2020, Credence Medsystems, US-based drug delivery, and specialty pharmaceutical company has collaborated with Schott AG, a German-based glass and glass-ceramics manufacturing company. The collaboration is to integrate Credence's Companion technology with Schott's refillable syringe glass and polymer syringe systems and provide an innovative and differentiated offering for the delivery of injectable medications via prefilled syringes.

The growing prevalence of chronic diseases such as diabetes, cancers are contributing to the growth of the single-chamber prefilled syringes market. According to the International Diabetes Federation, in 2019, approximately 463 million adults are living with diabetes and by 2045 it is estimated to be 700 million adults around the world, and 1 in 5 adults above 65 will have diabetes.

According to the American Cancer Society, in 2021, 1.9 million new cancer cases would be registered. Diabetes patients who require insulin therapy when medicines could not control their blood glucose levels, the diabetes patients use the single-chamber prefilled syringe. Therefore, the growing prevalence of chronic diseases such as diabetes and cancers drives the market for single-chamber prefilled syringes.

Companies Mentioned

  • Baxter

  • BD

  • Catalent

  • Gerresheimer

  • Nipro

  • Schott

  • Stevanato

  • Terumo

  • Vetter Pharma

  • Weigao

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting